The three serotypes of reovirus differ markedly in their response to a variety of chemical inactivating agents. We used intertypic recombinants containing various combinations of genes derived from the parental serotypes to study the basis of these differences. In addition to recombinants derived from types 1 and 3, and 2 and 3, we were able to isolate recombinants derived from types 1 and 2, suggesting that these two serotypes also undergo unrestricted reassortment. The intertypic recombinants behaved like one parent or the other in the presence of the inactivating agents and allowed us to determine the genes responsible for each difference. Recombinants derived from crosses between wild-type parental serotypes produced straightforward results, while recombinants derived from mutagenized, temperature-sensitive parents often did not. Sensitivity to 2.5 M-guanidine-HC1 and pH 11 was determined by the S1 gene, sensitivity to 55 °C and 1 ~o SDS was determined by the $4 gene, and sensitivity to 33~ ethanol and to 1 ~ phenol was determined by the M2 gene. Thus, relatively nonspecific chemical agents appear to have their predominant effect on specific proteins of the reovirus virion.
INTRODUCTION
The mammalian reoviruses are classified as enteric viruses by their site of isolation and by their chemical and physical properties. These properties include resistance to proteolytic enzymes, acid, detergents and heat (Bitton, 1980) . The biochemical and structural properties that allow the reoviruses, and other enteric viruses, to resist inactivation by these agents are not known. The genetic organization of mammalian reoviruses presents a unique opportunity to gain insight into the nature of the virus components responsible for determining the responses to such treatments. The three serotypes of human reoviruses are able to reassort dsRNA gene segments in mixed infection to produce recombinants (reassortants). These recombinants carry various combinations of discrete genes derived from the two parental serotypes. When two serotypes of reovirus differ in a biological or structural property, we have shown that intertypic recombinants can segregate the difference and thereby allow us to identify the gene(s) which specifies the difference (Fields, 1981) . In this report, we show that the three reovirus serotypes differ in their sensitivity to detergents, heat, high pH and several organic denaturants. Intertypic recombinants segregate these differences and have allowed us to determine the genes responsible.
METHODS

Virus and cells.
Mouse L cells were maintained in suspension culture as described previously (Ramig et al., 1977) . Reovirus serotypes 1 (Lang), 2 (Jones) and 3 (Dearing) are those described previously and used by this laboratory (Ramig et al., 1977) . Wild-type (wt) refers to these non-mutagenized, temperature-insensitive laboratory stocks.
Virus purification. L cells (2.5 x 108) in suspension culture were centrifuged and resuspended in Puck's medium containing 1 ~ foetal calf serum (Sterile Systems, Logan, Utah, U.S.A.) and 1 ~o 2 M-MgC12 at a density of 1 × l0 T ceUs/ml. Second-passage reovirus stock was added at a multiplicity of 5 and adsorbed for 30 min at 23 °C. The infected cells were diluted to 5 x 105 cells/ml with Joklik's modified Eagle's medium containing 1 ~ foetal calf 0022-1317/82/0000-5129 $02.00 © 1982 SGM D. DRAYNA AND B. N. FIELDS serum and 4% y-globulin-free newborn calf serum (VSP newborn calf serum; Biocell Laboratories, Carson, Ca, U.S.A.) and incubated in suspension at 32 °C until the viable cell count fell to 2.5 x 105 cells/ml (usually within 72 h). Virus was purified from the infected cells by a modification of the method of Smith et al. (1969) . The infected cells were centrifuged, the supernatant discarded, and the pellet resuspended in 10 ml homogenization buffer (0-01 M-Tris-HC1 pH 7.4, 0.25 M-NaCI, 0.01 M-fl-mercaptoethanol). The cells were disrupted to 10 s of sonication at full power on a Braunsonic 1510 sonicator. Sodium deoxycholate was added to a final concentration of 0-1% and incubated at 4 °C for 30 min. An equal volume of trichlorotrifluoroethane (Freon; Fisher Chemical Co.) was added and the mixture was emulsified by sonication for 30 s at full power. The emulsion was centrifuged for 5 min at 10000g, and the resolved aqueous phase was removed and reextracted with 1 vol. of Freon. The resultant aqueous phase was layered directly on to a preformed CsC1 density gradient (1.2 to 1.4 g/ml) in an SW41 rotor tube and centrifuged at 130000g for 2 h. The virus band was collected, dialysed exhaustively against 0.15 M-NaCI, 7-5 mM-MgC12, 5 mM-Tris-HCl pH 7-4, and stored at 4 °C. Virus concentration was determined by A26 o, using the formula 1 A26 o = 2-1 x t012 particles/ml.
Virus inactivation. Virus inactivation experiments were performed using virus that had been purified on density gradients less than 10 days previously. The particle/p.f.u, ratio of each virus stock was between 30 and 80; most were about 50. For each experiment, the virus stock was diluted to a concentration of 2 x l09 p.f.u./ml (a 500-fold or greater dilution) in 2.5 ml of the appropriate diluent. Samples of 0-1 ml were withdrawn at intervals and the inactivation stopped by a 100-fold dilution into gelatin-saline buffer at 4 °C (Fenner, 1958) . Reaction conditions were as follows: for untreated controls, virus was diluted into gelatin-saline and incubated at 37 °C; for heat inactivation, virus was diluted into gelatin-saline maintained at 55 °C; for guanidine inactivation, virus was diluted into gelatin-saline containing 2.5 ~-guanidine-HC1 (Eastman Kodak) maintained at 37 °C; for alkali inactivation, virus was diluted into gelatin-saline to which 10 M-NaOH had been added to bring the pH to 11.00 (at this pH, the gelatin-saline is buffered by an NaOH-NaCI buffer system); phenol and ethanol inactivations were carried out at 37 °C in gelatin-saline to which 1% phenol (J. T. Baker Chemical Co., Philipsburg, N.J., U.S.A.) and 33%/00 ethanol (U.S. Industrial Chemical Co., New York, N.Y., U.S.A.) were added respectively.
The pH of all solutions was checked before and after each experiment to ensure that no change had taken place as a result of the addition of the inactivating agent, or during the course of the reaction.
Titre of infectious virus in each aliquot was determined by plaque assay on L cell monolayers as described previously (Rubin & Fields, 1979) .
Isolation ofrecombinants. Recombinants were isolated by one of two methods. For the first method, 106 L cells were co-infected with M1-33 and ts2-112, temperature-sensitive strains of types 1 and 2 bearing ts mutations in different recombination groups (Ahmed & Fields, 1981; R. A. Ahmed, unpublished results) . The cells were infected with 5 p.f.u./cell of each parent and incubated at 31 °C. After 48 h, the cells were frozen and thawed twice and the resulting lysate diluted and plated on L cell monolayers at 39 °C, the non-permissive temperature. Wellisolated plaques were picked from plates with fewer than five plaques into 2 ml gelatin-saline and refrigerated overnight at 4 °C. First-passage stocks were inoculated with 1 ml of the gelatin-saline suspension and incubated at 37 °C until extensive c.p.e, developed. The dsRNA genome of each was examined as described previously (Ramig et al., 1977; Sharpe et al., 1978) . Putative recombinants (50 % of the plaques picked) were plaque-purified again and their dsRNA profiles reexamined to confirm their genotypes. The plating efficiency (39 °C/31 °C) of each recombinant was determined by plaque assay on L cell monolayers. All recombinants isolated by this technique were ts +, with a plating efficiency of f> 0.1 (data not shown). The 1 x 2 recombinants derived in this manner are referred to as 'group A 1 x 2 recombinants'.
The second method was identical to the first except that cells were co-infected with ts ÷ reovirus types 1 (Lang) and 2 (Jones), or ts ÷ types 1 (Lang) and 3 (Dearing). The progenies of these crosses were plated at 31 °C and plaques were picked and screened for recombinants as described above. These procedures yielded recombinants at a frequency of 1-8% of the plaques picked from the cross between types 1 and 2, and a frequency of 12% of the plaques from the cross between types 1 and 3. The 1 x 2 recombinants derived in this manner are referred to as 'group B 1 x 2 recombinants'.
RESULTS
Reovirus serotypes differ in their response to many chemical agents
Reoviruses, like other enteric viruses, are remarkably resistant to a variety of chemical inactivating agents. For example, the laboratory strains of type 1 (Lang), 2 (Jones) and 3 (Dearing) did not lose infectivity when incubated at 37 °C for 20 min in the presence of 0.5% phenol, 20% ethanol, 5 M-urea, pH 3 buffer, 10% deoxycholate, or at 48 °C (data not shown).
When treated under more stringent conditions with each of these agents, the three reovirus serotypes displayed marked differences in their responses. These responses shared certain features. First, although the absolute level of inactivation of a given serotype caused by a particular agent varied considerably over many experiments, the relative responses of the three serotypes were reproducible, and were independent of the extent of purification of the virus stocks used. For example, in the presence of 2-5 M-guanidine-HC1, a CsCl-purified stock of type 3 decreased 2.5 lOglo in titre in 20 min, but a CsCl-purified stock of type 1 decreased only 0.5 log10. Less purified preparations of types 3 and 1 analysed in the same experiment fell 1.7 loglo and 0.2 loglo in titre respectively. Thus, type 3 was about 50 times more sensitive to guanidine-HC1 than type 1, regardless of the extent to which the stocks had been purified. Second, although these experiments were performed using gelatin-saline as a buffer, the relative sensitivities of the three reovirus serotypes remained the same when treated in other buffers, including Tris-HC1 and HEPES (data not shown). Third, the absolute responses varied with different concentrations of the inactivating agent, but the relative responses did not. Because of the variability in the absolute amount of inactivation, each inactivation experiment was done at least three times. The inactivation data presented below represent a single typical experiment unless otherwise stated. Different concentrations of each inactivating agent were tested until a single concentration was found at which one serotype was inactivated while another serotype remained largely unaffected. The final concentrations used and the resulting behaviour of the three reovirus serotypes are shown in Table 1 . In addition to the agents listed in Table 1 , three other agents, 0.5% H202, 1% NaOC1 and 1% formalin, revealed slight differences in stability among the three serotypes, but these differences were not great enough or reproducible enough to allow further studies. The three reovirus serotypes were inactivated in an identical manner by u.v. irradiation.
Construction of intertypic recombinants
The strategy we have used to identify the gene(s) responsible for the different responses of the reoviruses to chemical and physical agents has been to test intertypic recombinants and thereby determine which gene segregates with the property being examined. Four treatments, 1% SDS, pH 2, pH 11 and 55 °C, exhibited the greatest differences between type 1 and type 2 (i.e. type 3 behaved in an intermediate fashion). We therefore constructed a series of recombinants between type 1 and type 2 to enable us to determine the gene(s) responsible for these differences. Temperature-sensitive mutants of type 1 (M 1-33) and type 2 (ts2-112) were crossed and recombinant progeny obtained as described in Methods. All dsRNA segments of types 1 and 2 could be readily distinguished on the basis of their electrophoretic mobilities when the Tris-glycine system and the Tris-acetate system (Ramig et al., 1977) were used in combination. In addition, since the S1 gene dsRNA mobility difference between types 1 and 2 was subtle (Hrdy et al., 1979; Ramig et al., 1977) , its parental origin was confirmed by examining the electrophoretic mobility of the S 1 gene product, the al polypeptide (data not shown). Genotypes of the recombinants obtained in this manner (designated group A1 × 2 recombinants) are listed in Table 2 . All of these ts ÷ recombinants carry the $4 gene from type 1, because ts2-112 is a tsG, which carried the ts lesion in the $4 gene (Ahmed & Fields, 1981 ; Mustoe et al., 1978 a) . Since the type 1 mutant (M1-33) is leaky, the site of its ts lesion has not been mapped (D. Drayna & B. N. Fields, unpublished data; see Table 2 ).
These recombinants were useful in the study of several properties of reovirus, as described below. As our studies progressed, however, it became clear that such recombinants, derived 3  3  3  3  1  3  3  3  3  3  -1  1  G2  1  3  1  1  1  1  3  |  1  1  1  -1  G16  1  1  1  3  1  1  1  1  1  1  -!  1  H14  1  1  3  1  1  1  1  1  3  1  1  H15  1  3  3  1  3  3  3  3  3  1  1  3  3  H17  3  3  3  1  3  3  1  3  3  1  1  3  3  H9  3  3  1  3  1  1  3  3  3  3  3  -1  H24  1  1  1  1  1  1  1  1  1  3  3 --* Type 1, resistant; type 3, sensitive.
from mutagenized, temperature-sensitive parents had certain disadvantages. Recombinants derived from mutagenized parents occasionally displayed anomalous or intermediate behaviour. Because of the possibility that these recombinants contain other temperature-insensitive alterations as a result of mutagenesis (see below), we constructed two additional series of recombinants. These recombinants were constructed in co-infected L cells with wt types 1 and 2 or wt types 1 and 3 as described in Methods. The genotypes of the recombinants thus obtained are listed in Tables 3 (group B 1 × 2 recombinants) and 4 respectively.
Genetic mapping of the site of action of pH 11, 55 °C, 1% SDS and pH 2 treatments
The type 1 × 2 recombinants (groups A and B) allowed us to examine the genetic basis of the differences in the stability of these two serotypes toward high temperature, alkali, ionic detergents and acid. 
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Alkali inactivation, pH 11
The typical behaviour of the parental types and the group A recombinants in the presence of pH 11 is shown in Fig. 1 . The recombinants fell into two general groups, those that lost 0.5 log10 or less in infectivity(the parental type 1 M1-33, 1 x 2-14, 1 x 2-17, 1 x 2-29 and 1 x 2-31), and those whose infectivity fell approximately 2 loglo (the parental type 2 ts2-112, 1 x 2-6, 1 x 2-23 and 1 x 2-24). Examination of the genotypes in Table 2 shows that all recombinants which possess the S1 gene of type 1 behave like type 1, while those that possess the S1 gene of type 2 behave like type 2. Clone 1 x 2-23, for example, contains three genes from type 2 (M3, S1 and $3). The genes M3 and $3 code for proteins that are non-structural and are therefore not found in the virion. Thus, virions of clone 1 x 2-23 have a single poiypeptide species from type 2, the S1 gene product, and had a sensitivity to pH 11 virtually indistinguishable from type 2 itself. In all the other recombinants the pattern of response was also invariably identical to that predicted by the presence of the S1 gene. Each other RNA segment was excluded in at least one recombinant. Thus, reovirus sensitivity to pH 11 is determined solely by the S1 gene product.
Heat inactivation, 55 °C
The group A 1 x 2 recombinants allowed us to investigate the basis for the difference in stability between types 1 and 2 virions at 55 °C. The type 1 parent M1-33 decreased less than 1 log~o in titre when treated at 55 °C for 20 min, while the titre of the type 2 parent ts2-112 fell 3 log~o. In a typical experiment, all the type 1 x 2 recombinants behaved like type 1, i.e. lost less than 1 log~o in titre under these conditions (Fig. 2) . All of the group A 1 x 2 series of recombinants have the $4 gene of type 1 because the ts type 2 parent carries the ts lesion in the $4 gene (see "Construction ofintertypic recombinants' above). Clone 1 x 2-18, for example, behaved like type 1 and carries only the $4 gene from type 1; all other genes are from type 2. The genotypes of the other recombinants tested also exclude all genes except $4 at least once. These results strongly suggested that the $4 gene of type 1 conferred resistance to 55 °C. However, since our collection of recombinants all behaved like type 1, it was possible that any combination of type 1 and type 2 genes produced a heat-resistance phenotype. We therefore turned to our collection of type 1 x type 3 recombinants (Table 4) . The difference in stability to 55 °C between types 1 and 3 was less than the difference between types 1 and 2 (Table 1) 3 . Effect of 55 °C treatment on reovirus type 1, type 3, and type 1 x 3 recombinants. Types 1 and 3 are wild-types 1 (Lang) and 3 (Dearing) respectively. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1 . Fig. 4 . Effect of 1 ~ SDS treatment on reovirus type 1, type 2, and group A 1 x 2 recombinants. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1. the difference between types 1 and 3 was reproducible, the experimental variability made the results less clear-cut. Nevertheless, in a typical experiment shown in Fig. 3 , the recombinants having the $4 gene of type 3 (clones H9 and H24) were significantly more sensitive to 55 °C than those with the $4 gene of type 1 (clones H15, H17 and G2). Clone H24, for example, contains only the $4 gene of type 3; all other genes are from type 1. The sensitivity of H24 to 55 °C was roughly the same as type 3. The genotypes of the other recombinants tested exclude all other genes at least once. These results from type 1 x 3 recombinants thus agree with the results from the group A1 x 2 recombinants, and show that heat resistance is not simply due to any combination of genes from the two parents, but that the behaviour of reovirus at 55 °C can be determined by the $4 gene alone.
Detergent inactivation, 1~ SDS
The basis for the sensitivity of reovirus to 1% SDS was also examined with the group A 1 x 2 recombinants. Ts ÷ type 1 (Lang), ts + type 2 (Jones), ts type 1 (M1-33), ts type 2 (ts2-112), and several group A 1 x 2 recombinants were treated with 1 ~ SDS (Fig. 4) . The results of such treatment revealed several anomalous behaviours among the strains tested. First, M1-33 and ts2-112, the ts parents used to generate the group A 1 x 2 recombinants, did not respond like wild-types 1 and 2 in the presence of SDS; the difference between these two strains in sensitivity to SDS was much less than the difference between ts ÷ types 1 (Lang) and 2 (Jones). We have previously shown that reovirus ts mutants derived by mutagenesis contain temperature-insensitive mutations not linked to the ts lesion which alter some of the properties of the virion (Cross & Fields, 1976; Rubin & Fields, 1979) . It is thus possible that these ts mutants (M1-33 and ts2-112) contain several mutations including some that could affect the response of the virus to SDS. Second, although the group A 1 × 2 recombinants were all significantly more sensitive to SDS than ts ÷ type 2 (Jones), they displayed considerable variation in the extent of inactivation. For example, clone 1 x 2-18 contains only the $4 gene of type 1 (the sensitive parent); all other genes are from type 2 (the resistant parent). The striking SDS sensitivity of this clone would normally imply that the $4 gene specifies SDS sensitivity. However, other clones (1 x 2-24, 1 x 2-29) displayed sensitivities that were intermediate to the sensitivities of the two ts parents, while clone 1 x 2-18 was actually more sensitive than M1-33, the ts type 1 parent. Thus, while these experiments suggested that $4 specifies SDS sensitivity, the anomalous behaviour of the ts parents and these recombinants raises uncertainties about this conclusion. . Effect of 1 ~o SDS treatment on reovirus type 1, type 2, and group B 1 x 2 recombinants. Types 1 and 2 are wild-types 1 (Lang) and 2 (Jones) respectively. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1 . Fig. 6 . Effect of 2.5 M-guanidine-HCl treatment on reovirus type 2, type 3, and 2 × 3 recombinants. Types 2 and 3 refer to the wild-type parents type 2 (Jones) and 3 (Dearing) respectively. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1 .
To assign the site of SDS action less ambiguously, we therefore constructed a series of recombinants derived from crosses between unmutagenized types 1 and 2 as well as unmutagenized types 1 and 3 (see Methods). The genotypes of the 1 × 2 recombinants obtained (designated group B 1 x 2 recombinants) are listed in Table 3 .
The typical behaviour of some of these recombinants in the presence of 1% SDS is shown in Fig. 5 . In this experiment, the titre of the type 2 parent rose slightly, while the titre of the type 1 parent fell more than 1 loglo. The behaviour of all the recombinants was not significantly different from type 1 (Lang); no clones displayed sensitivities greater than either of the parents. In every recombinant, the S1 and $4 genes were derived from type 1, indicating that the S1 and/or the $4 gene was responsible. Unfortunately, the small number of 1 × 2 group B recombinants obtained all contained both the S1 and $4 genes of type 1. Recombinants containing the $4 gene from type 2 have rarely been obtained without a selective pressure, possibly because the S1 or $4 genes of type 2 lead to low yield (Mustoe et al., 1978a; Ramig et al., i978) .
Thus, although the recombinants derived from crosses between unmutagenized parents did not allow us to differentiate between S1 and $4 in these experiments, they did overcome the variability observed with the recombinants from mutagenized parents. Since a number of the group A 1 x 2 recombinants clearly excluded the S1 gene (for example clones 1 × 2-18 and 1 × 2-23), the combined genetic analysis strongly suggests that the site of action of 1% SDS is the $4 gene product. Biochemical studies in the accompanying paper (Drayna & Fields, 1982) further support the conclusion that the $4 gene determines the sensitivity of reovirus to 1% SDS.
Acid inactivation, pH 2
We were unable to determine the gene(s) responsible for inactivation by pH 2. Although types 1 and 2 displayed a difference in stability of more than 1 log~o in the presence of pH 2, neither set of 1 × 2 recombinants reproducibly segregated the parental phenotypes well enough to allow us to determine the gene responsible. The difference in response between types 1 and 2 was insufficient to allow analysis by this method.
Inactivation by 2.5 M-guanidine-HCl
A collection of recombinants derived from a mixed infection between wt types 2 and 3 (Sharpe & Fields, 1982) . Effect of 1 ~ phenol treatment on reovirus type 1, type 3, and 1 x 3 recombinants. Types 1 and 3 refer to the wild-type parents type 1 (Lang) and 3 (Dearing) respectively. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1 . Fig. 8 . Effect of 33 ~ ethanol treatment on reovirus type 1, type 3, and 1 x 3 recombinants. Types 1 and 3 refer to the wild-type parents type 1 (Lang) and 3 (Dearing) respectively. The extent of inactivation was determined by plaque assay and is plotted as described in the legend to Fig. 1 . •L1 L2 L3  169  3  3  2  204  2  2  2  225  3  3  3  242  3  3  3  269  2  3  2 Origin of gene Response ~ to M1 M2 M3 S1 $2 $3 $4 guanidine *  2  3  2  2  3  3  2  2  2  2  2  2  2  2  3  2  2  2  3  3  3  3  3  3  3  3  3  3  3  3  2  3  2  2  2  3  3  2  3  3 * Type 2, resistant; type 3, sensitive.
these two serotypes to 2.5 M-guanidine-HC1. The genotypes of the recombinants tested are listed in Table 5 . The recombinants typically fell into two groups (Fig. 6 ). The first group showed a slight increase in titre, similar to type 2 (clones 204 and 169). The other group fell by about 1 log~0 in titre as did type 3 (clones 242, 269 and 225). The clones which behaved like type 2 all contain the S1 gene of type 2, while clones which behaved like type 3 carry the S1 gene of type 3 (Table 5) . Since all other genes are excluded once or more, these results indicate that the S 1 gene is the major determinant of reovirus sensitivity to guanidine-HCl. Some clones, particularly 169, displayed an intermediate phenotype, suggesting that other virus genes may have some effect on the stability in the presence of guanidine-HC1. These minor effects were not large enough to assign to any particular gene.
Inactivation by 1% phenol
The greatest difference in sensitivity to 1 ~ phenol was between serotypes 2 and 3 ( Table 1) . The difference between types 1 and 3 was almost as large, however, and recombinants between types 1 and 3 grew to a high titre much more reliably than recombinants between types 2 and 3. We therefore examined the basis for the sensitivity to 1 ~ phenol by using recombinants between types 1 and 3. In experiments using recombinants derived from mutagenized parents (Sharpe & Fields, 1982) we observed results analogous to those obtained in previous experiments with SDS. Although the behaviour of some of these recombinants suggested that the M2 gene was important, many of the recombinants displayed phenol sensitivities unlike either type 1 or type 3 (data not shown). We therefore used the recombinants generated from crosses between wt types 1 and 3 as described in Methods. The genotypes of the recombinants used are listed in Table 4 . When these recombinants were treated with 1% phenol (Fig. 7) , they behaved in one of two ways. Some, like the type 1 parent (Lang), fell by about 1 log10 in titre (clones E3, G2, GI6, and H9); the others (H15 and H17) lost about 3 loglo, like the type 3 parent (Dearing). Recombinants with the M2 gene of type 1 behaved like type 1, while the recombinants with the M2 gene of type 3 behaved like type 3 (Table 4 ). All genes other than M2 were excluded at least once. Clone E3, in particular, has only a single gene from type 1, the M2 gene, and has phenol sensitivity indistinguishable from that of type 1. Thus, all the data indicate that the M2 gene determines the sensitivity to 1% phenol.
Inactivation by 33%o ethanol
The type 1 x type 3 recombinants derived from crosses between unmutagenized parents were used to examine the basis of reovirus sensitivity to 33 % ethanol. The genotypes of the recombinants tested are listed in Table 4 . The sensitivities of the recombinants typically fell into two groups (Fig. 8) : those which dropped 1 to 2 loglo in titre [parental type 1 (Lang), E3, H14 and GI6] and those which fell 4 to 5 logao in titre [parental type 3 (Dearing), H15 and H17]. The recombinants containing the M2 gene of type I behaved like type 1, while recombinants with the M2 gene of type 3 behaved like type 3 (Table 4 ). The genotypes of the recombinants used excluded all other genes at least once. These results indicate that the M2 gene determines the sensitivity of reovirus to ethanol. Some recombinants, although they behaved in a manner similar to types 1 or 3, displayed an intermediate phenotype (E3, H17), indicating that other genes may have an effect on reovirus sensitivity to ethanol. These minor effects were variable and were not large enough to assign to any particular gene. DISCUSSION We have demonstrated that the three closely related serotypes of reovirus differ widely in their response to a variety of chemical agents. In an attempt to determine which virus gene(s) specify the difference between the parents, we examined the response of a number of intertypic recombinants that carried various combinations of genes from the parental serotypes. To examine the properties which differed most widely between types 1 and 2, we first constructed a number of 1 x 2 recombinants from temperature-sensitive strains of type 1 and type 2. Our ability to isolate such recombinants demonstrates that type 1 and type 2 can undergo apparently unrestricted reassortment in mixed infections, as previously demonstrated for types 1 and 3 and types 2 and 3.
These recombinants derived from crosses between two ts parental viruses, as well as other recombinants previously derived from ts type 3 and type 1 parents segregated the parental sensitivities, i.e. behaved like one or the other parental strain in their sensitivity to these agents and, in at least one case (pH ll), allowed us to determine the virus gene responsible for the difference. In other cases, however, the recombinants derived from crosses between temperature-sensitive parents gave less clear-cut results. We have previously shown that temperaturesensitive parental strains derived by chemical mutagenesis contain silent mutations independent of the ts lesion (Cross & Fields, 1976; Rubin & Fields, 1979) . Ts ÷ recombinants derived from these mutagenized parents still contain these mutations if they are in genome segments outside the ts segment. In order to minimize the possibility that the stocks we used contained such silent mutations, we constructed a number of recombinants by mixedly infecting unmutagenized wt reovirus serotypes 1 and 2 and screening the dsRNA genotypes of a large number of progeny. When these recombinants were tested by treatment with the various chemical agents, unambiguous determination of the virus gene responsible was possible in almost all cases.
These results thus indicate that individual components of the reovirus capsid determine the sensitivity to a variety of chemical inactivating agents. Most of the agents we studied are thought to be non-specific (Drayna & Fields, 1982) , and it is known that a large number of sites on the virion are affected by them (Gard, 1957) . Our studies, however, demonstrate that specific structures or sites on the reovirus virion mediate the primary inactivation by these agents especially in limiting concentrations of these agents. Thus, the S 1 gene, encoding a l, the virus haemagglutinin (Weiner et al., 1978) determines the behaviour of reovirus in the presence of D. DRAYNA AND B. N. FIELDS 2"5 M-guanidine-HC1 or pH 11. The $4 gene, encoding ~r3, a major outer capsid polypeptide (Mustoe et al., 1978b) determines the behaviour of reovirus in the presence of 1 ~ SDS or at 55 °C. Sigma 3 is the virion component which is responsible for the inhibition of host cell RNA and protein synthesis (Sharpe & Fields, 1982) . The M2 gene, encoding ~tlC, the outer capsid polypeptide that mediates the response to proteolysis (Joklik, 1972 (Joklik, , 1980 Mustoe et al., 1978b; Rubin & Fields, 1979) determines the response of reovirus to 1 ~ phenol or 33~ ethanol.
These properties seem to be generally applicable among all mammalian reoviruses as indicated by two lines of evidence. First, sensitivity to 55 °C in both laboratory strains (type 2 and type 3) is determined by the $4 gene (see above), although these two strains are genetically divergent (Joklik, 1980) . Second, we have made a preliminary examination of some of these properties in a variety of reovirus field isolates. One such isolate (designated T-3 H/TA) is classified serologically as type 3 and yet displays many differences when compared with type 3 (Dearing) (Hrdy et al., 1979) . T-3 H/TA is much more phenol-resistant than type 3 (Dearing), and this difference in phenol resistance of T-3 H/TA is due to its M2 gene (D. Drayna, unpublished data). Thus, in both cases examined (heat sensitivity and phenol sensitivity), resistance to the inactivating treatment is determined by the same gene in widely different mammalian reovirus strains. Therefore, despite the broad reactivity of most of the chemical agents we studied, our results show that they act at specific sites on reovirus, and that these sites of action are consistent in other mammalian reovirus strains.
The response of viruses to chemical and physical inactivating agents has been widely used for a number of years for different reasons. For example, (i) high pH has been used to inactivate viruses in water supplies (Bitton, 1980; Melnick et al., 1978) , (ii) Mg 2÷ is added to stabilize poliovirus vaccine strains against heat inactivation (Wallis & Melnick, 1962) , (iii) heat stability of the virus capsid (e.g. poliovirus) is frequently used as a marker in genetic studies (Cooper, 1977) , and (iv) several such properties (e.g. acid sensitivity of rhinoviruses) are utilized in the classification of viruses (Davis et al., 1980; Fenner et aL, 1974) . In spite of their wide usage, surprisingly little is known concerning the specific modes of action of most chemical and physical treatments. In part this is due to the difficulty in determining their precise sites of action. In addition, these problems may have been mainly of interest to those specializing in environmental virology or in the biology of viruses, and less to molecular biologists or biochemists. It is clear that with recent genetic and molecular approaches, the time is ripe for a more detailed elucidation of the nature of the responses of viruses to physical and chemical treatments.
Our studies thus indicate that the ultimate structural basis of stability of reovirus and possibly other icosahedral viruses toward harsh chemical and physical treatments lies in discrete virus components. In reovirus, these structures are encoded by modular genetic units which can be exchanged by reassortment. This exchange would generate a variety of genotypes encoding polypeptides with different responses to environmental conditions. Such variability would allow reovirus to survive in different environmental conditions. Although these studies have identified specific sites where chemical and physical agents affect the mammalian reoviruses, they do not provide insights into the mechanism of inactivation. A preliminary biochemical analysis concerning the nature of the lesions induced by these treatments appears in the accompanying paper (Drayna & Fields, 1982) .
